USP Opens Biologics Standards for Public Comment

PharmTech.com reports that the USP has published new biologics standards. These published standards are now open for public comment. The release marks a significant step in the regulatory process. Stakeholders are invited to review the proposed standards for biologics. The public comment period allows for feedback from the industry. This initiative is aimed at refining the quality benchmarks for biologics. The USP seeks to ensure the standards meet necessary requirements. The publication of these standards was detailed by PharmTech.com.